Roberts, A. W., Advani, R. H., Kahl, B., Persky, D., Sweetenham, J. W., Carney, D. A., . . . Seymour, J. F. (2015). Phase 1 Study of the Safety, Pharmacokinetics, and Antitumour Activity of the BCL2 Inhibitor Navitoclax in Combination With Rituximab in Patients With Relapsed or Refractory CD20+ Lymphoid Malignancies. Br J Haematol.
Trích dẫn kiểu ChicagoRoberts, Andrew W., et al. "Phase 1 Study of the Safety, Pharmacokinetics, and Antitumour Activity of the BCL2 Inhibitor Navitoclax in Combination With Rituximab in Patients With Relapsed or Refractory CD20+ Lymphoid Malignancies." Br J Haematol 2015.
Trích dẫn MLARoberts, Andrew W., et al. "Phase 1 Study of the Safety, Pharmacokinetics, and Antitumour Activity of the BCL2 Inhibitor Navitoclax in Combination With Rituximab in Patients With Relapsed or Refractory CD20+ Lymphoid Malignancies." Br J Haematol 2015.